ReviewOncology letters2025

Targeting menin in lysine methyltransferase 2A/nucleophosmin-mutated leukemia: A novel strategy from epigenetic dysregulation to clinical therapy (Review).

Junjie Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.